We use cookies to improve your experience on this site. By viewing our pages, you give us consent to use cookies. Find out more.

Don’t invest unless you’re prepared to lose all the money you invest. NextFin promotes high - risk investments and you are unlikely to be protected if something goes wrong.
Take 2 minutes to learn more.

Filters

Equity Crowdfunding Pitches

Showing results
42Genetics is a biotechnology company that endeavours to unlock genomic data for health organisations by providing data-driven solutions for diagnostics and discovery at scale. It argues that 1 in 17 people, or about 3 million people in the UK, will be affected by a rare disease such as different types of cancers, cystic fibrosis and Huntington’s disease. 42Genetics seeks to address this crisis. The company completed a validation project with Cambridge University, hosting and processing 15,000 whole genomes. 42Genetics also claims to reduce the size of a digitised human genome from the current 500 GB to less than 5GB in size making it easier to transfer via cloud and store alongside large population groups. Its work was published in 'Nature' journal along with NIHR and Genomics England in February 2020. The company intends to become a contender in the genomics industry that is projected to grow to $82.6 billion by 2027. 42 Genetics will use the investment to progress precision medicine programs, enable fruitful diagnostics, and boost its research process.

Pitch Rated

52%

Insufficient Data

rating powered by

CROWD RATING™

days to go: Expired investment: £854,001
Founded by Glen Elliot, 2005 in the early days of the professional video gaming industry, Esports Gaming League (EGL) has since helped shape esports into a fast-growing phenomenon. The brand aims to be at the forefront of esports starting in Europe before expanding globally into Asia, South America, and the Middle East. It has worked with clients such as KFC, Science Museum, Activision among other brands. The esports industry is valued at $1.1 billion globally for 2019, and EGL has positioned itself to be at the heart of it. The platform has 315,000 registered users engaging in regular tournaments online. With the funds raised, EGL aims to enhance its tournament platform and make the process of playing and competing easier. It will also work with major game developers across multiple platforms and make their titles esportable.

Pitch Rated

52%

Insufficient Data

rating powered by

CROWD RATING™

days to go: Expired investment: £189,540
DocuChain has developed a customisable SaaS platform designed for Risk, Process, Asset and Compliance Management, providing Chain of Custody solution to the enterprise. The global market of content collaboration market is about to reach $18.78 billion by 2025. The industry is growing at a CAGR of 17.8%. DocuChain has 13 Non-Disclosure Agreements for knowledge sharing: FTSE, NYSE, NASDAQ and Big4 audit companies. It has also received a pilot request from an FTSE100 packaging company for a pharma application demo. With the proceeds, the company is planning to support demos, hire two technical support members and for product enhancements.

Pitch Rated

52%

Insufficient Data

rating powered by

CROWD RATING™

days to go: Expired investment: £119,620
Bitstocks is a financial technology application built entirely on blockchain. The company intends to bring to customers the benefits of bitcoin in a simple & accessible personal account format. It asserts that 76% of UK adults use online banking. Its product, Gravity, currently offers BSV, BTC, GBP & EUR pairings, with investment accounts for customers to buy, sell & store bitcoin. The company is registered with the Financial Conduct Authority (FCA) and integrated with Faster Payment System & Single Euro Payments Area provider. Bitstocks has 1,800+ registered customers, with 650+ joining through referrals. It will use the investment to scale & develop the next phase of Gravity, bring forth stablecoin to enable tokenised global micropayments, and introduce personal accounts, debit cards, savings & loans.

Pitch Rated

51%

Insufficient Data

rating powered by

CROWD RATING™

days to go: Expired investment: £1,105,596
PRYNTD is an immersive on-demand and live-streaming platform. The company enables content creators to create, convert and share 2D content and live streams as immersive experiences that audiences can access on their smartphones, tablets, computers, TVs, augmented and virtual reality devices. PRYNTD claims that its website witnessed 200,000 views to date, supporting 100+ artists, and onboarding 50+ affiliate partnerships. The company aspires to dominate the immersive content market that is set to grow to $900 billion by 2026, with entities like Apple, Facebook, Microsoft as key players. PRYNTD has been applauded by UK innovation agency, 'Digital Catapult' and accepted to the Mayor of London's 'Growth With AI' programme. The company states it will use the investment to improve its technology, reach a wider audience, and maximise exposure for its creators.

Pitch Rated

51%

Insufficient Data

rating powered by

CROWD RATING™

days to go: Expired investment: £84,473
PCL Health is a Business-to-Business (B2B) Software-as-a-Service (SaaS) entity that aims to bring hospital-level care to anyone remotely. It asserts that the correct use of remote monitoring can reduce mortality by up to 45%. PCL Health intends to become a contender in the remote healthcare market that is set to touch $30 billion by 2023. It has developed CE rated medical-grade devices that use health algorithms combined with sensors and its proprietary range of apps to allow family members to proactively monitor the health of their loved ones, alongside carers and doctors, remotely. PCL Health has completed two pilots with 65 people and received a Letter Of Intent (LOI) from a National Health Service (NHS) Trust for a clinical trial. It won the 'Innovative Startup' competition at the 2019 Healthcare Unblocked event. PCL Health will use the investment for technology enhancement, running further pilot studies, and working capital.

Pitch Rated

51%

Insufficient Data

rating powered by

CROWD RATING™

days to go: Expired investment: £394,680
Please watch the video for more information

Pitch Rated

51%

Insufficient Data

rating powered by

CROWD RATING™

days to go: Expired investment: £472,570
UnderPinned gives freelancers a single, dedicated platform to learn how to build a successful business, find clients, manage their work, and help them get paid on time. The company aspires to build a connection with users that ensures everyone thrives through its accelerator programme, community, and content. UnderPinned asserts that its accelerator programme allows it to achieve day one unit profitability before converting users to subscribers. It claims to have made £12,772 in revenue with £8,000 spent on marketing in its first month of programme sales in January 2021. The company argues that COVID-19 has accelerated freelancing, moving away from traditional employment. UnderPinned has a community of over 20,000 subscribers and growing. It says itvwill use the investment to scale its team, marketing and product development as it focuses on expanding in the US and EU markets.

Pitch Rated

51%

Insufficient Data

rating powered by

CROWD RATING™

days to go: Expired investment: £629,086
Meeow is a company that seeks to offer unlimited, on-demand business networking. It argues that Covid-19 has changed the idea of networking with an increasing demand for in-person online networking solutions. Meeow aims to capture this sentient through its app. The company's AI-driven proprietary platform brings four people together for 1 hour in an interactive video session through a combination of random selection and machine learning. Meeow's ongoing BETA saw more than 420 Meeowists using its service. The company will use the investment for marketing its service network, further develop its platform, and expand its early adopter community to a minimum of 10,000 users by the end of 2021.

Pitch Rated

50%

Insufficient Data

rating powered by

CROWD RATING™

days to go: Expired investment: £125,235
Her.9 is a Direct-To-Consumer (DTC) female technology brand that caters to the needs of women during pregnancy. It cites research arguing that up to 40% of women taking prenatal vitamins may not be able to absorb the folic acid within the UK’s leading pregnancy brand. Her.9 aims to resolve this by employing DUOCAP technology. The company asserts that DUOCAP is a capsule-in-capsule delivery system which contains solubilised prebiotics in the outer capsule and probiotics in the inner capsule. The prebiotic releases immediately and the probiotic releases later allowing for targeted supplement delivery in the body. The prenatal supplements market is set to be worth $56 billion globally by 2024. Her.9 aims to be a notable contender in this segment. The company is raising investment to build its already established partnerships and execute its marketing strategy effectively.

Pitch Rated

50%

Insufficient Data

rating powered by

CROWD RATING™

days to go: Expired investment: £215,946
  • Internet Business Awards Category Award Winner 2015
  • Hertfordshire Business Awards Finalist 2014

As seen in:

  • The Guardian
  • Financial Times
  • Yahoo! Finance
  • The Times
  • The Daily Telegraph